In a turbulent market environment, Cytokinetics , Incorporated (NASDAQ:CYTK) stock has reached its 52-week low, trading at $41.69, with a sharp 14% decline just last week. According to InvestingPro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback